Earum Pharmaceuticals Limited
ListedSMEHealthcare & Pharmaceuticals · BSE
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in the trading, marketing, and distribution of pharmaceutical formulation products, with a portfolio of around 125 formulations including multivitamins, gynaecology drugs, steroids, antibiotics, cerebral activators, and gastrointestinal medicines. The company is also involved in trading active pharmaceutical ingredients such as Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP, and operates through two main business models—marketing its own branded formulations and trading generic formulations of other brands, with about 24 products manufactured by third parties and sold under its own brand. Earum Pharmaceuticals operates a well-equipped warehouse in Ahmedabad, Gujarat, and has a presence in both domestic and international markets including South East Asia, Latin America, and Africa, while focusing on expanding its global footprint, improving market capabilities, and maintaining high-quality product standards.
Price Band
₹36
Issue Size
₹7.00 Cr
Lot Size
3000 shares
GMP
—
Est. Listing
₹36
at current GMP
Subscribed
—
Open
21 Jun 2019
Close
26 Jun 2019
Allotment
1 Jul 2019
Refund
2 Jul 2019
Demat Credit
3 Jul 2019
Listing
4 Jul 2019
Last updated 12 days ago
Official Registrar Verification
Earum Pharmaceuticals Limited Allotment Status
Designated Registrar: Bigshare Services Private Limited
Allotment Date
1 Jul 2019
Basis finalization
Refunds Initiate
2 Jul 2019
Mandate release
Demat Credit
3 Jul 2019
Shares in demat
Listing Debut
4 Jul 2019
Trading begins
How to Check Earum Pharmaceuticals Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Bigshare Services Private Limited's allotment portal.
- Select Earum Pharmaceuticals Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Earum Pharmaceuticals Limited Public Issue & Market Profile
Earum Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹7 Crores. The shares are offered at a price band of ₹36 to ₹36 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Public Issue & Allotment Procedure:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 3000 shares (approx. ₹1,08,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Official Allotment Timelines & Registrar Guidance:
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2019-07-03, while un-allotted funds or UPI block mandates will be released on 2019-07-02.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.